Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1948 4
1949 2
1950 3
1951 1
1955 1
1959 2
1961 1
1963 2
1964 2
1965 5
1966 1
1967 2
1968 2
1970 2
1971 2
1973 1
1974 2
1975 3
1976 1
1979 1
1982 1
1983 3
1984 4
1985 3
1986 3
1987 3
1988 1
1989 2
1990 1
1991 3
1992 1
1993 3
1994 8
1995 4
1996 4
1997 7
1998 4
1999 8
2000 5
2001 7
2002 21
2003 19
2004 7
2005 19
2006 12
2007 26
2008 40
2009 13
2010 14
2011 23
2012 31
2013 32
2014 32
2015 35
2016 45
2017 29
2018 46
2019 62
2020 59
2021 71
2022 31
Text availability
Article attribute
Article type
Publication date

Search Results

714 results
Results by year
Filters applied: . Clear all
Page 1
Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial.
El-Khoueiry AB, Sangro B, Yau T, Crocenzi TS, Kudo M, Hsu C, Kim TY, Choo SP, Trojan J, Welling TH Rd, Meyer T, Kang YK, Yeo W, Chopra A, Anderson J, Dela Cruz C, Lang L, Neely J, Tang H, Dastani HB, Melero I. El-Khoueiry AB, et al. Among authors: lang l. Lancet. 2017 Jun 24;389(10088):2492-2502. doi: 10.1016/S0140-6736(17)31046-2. Epub 2017 Apr 20. Lancet. 2017. PMID: 28434648 Free PMC article. Clinical Trial.
ATAD3A on the Path to Cancer.
Teng Y, Lang L, Shay C. Teng Y, et al. Among authors: lang l. Adv Exp Med Biol. 2019;1134:259-269. doi: 10.1007/978-3-030-12668-1_14. Adv Exp Med Biol. 2019. PMID: 30919342 Review.
Changing Face of Prosthodontics.
Lang LA, García LT. Lang LA, et al. Dent Clin North Am. 2019 Apr;63(2):xi-xii. doi: 10.1016/j.cden.2019.01.001. Epub 2019 Feb 2. Dent Clin North Am. 2019. PMID: 30825995 No abstract available.
Serving as Trusted Messengers about COVID-19 Vaccines and Therapeutics.
McDougle L, Hewlett D Jr, Hutchins SS, Hood RG, Butler LM, Lang LK, Brooks OT, Caine VA, Whitley-Williams PN. McDougle L, et al. Among authors: lang lk. J Natl Med Assoc. 2021 Feb;113(1):6-7. doi: 10.1016/j.jnma.2021.01.003. J Natl Med Assoc. 2021. PMID: 33583497 Free PMC article. No abstract available.
Perivascular Epithelioid Cell Tumor of Urinary Bladder.
Wu YL, Lang L, Ma Q, Wu F, Zhang Y, Chen W, Yan XC, Duan GJ. Wu YL, et al. Among authors: lang l. Am J Clin Pathol. 2021 Jun 17;156(1):56-71. doi: 10.1093/ajcp/aqaa204. Am J Clin Pathol. 2021. PMID: 33336255 Review.
Molecular pathogenesis of hereditary hemochromatosis.
Liu J, Pu C, Lang L, Qiao L, Abdullahi MA, Jiang C. Liu J, et al. Among authors: lang l. Histol Histopathol. 2016 Aug;31(8):833-40. doi: 10.14670/HH-11-762. Epub 2016 Mar 31. Histol Histopathol. 2016. PMID: 27031690 Review.
Opioids in rheumatic diseases.
Lang LJ, Pierer M, Stein C, Baerwald C. Lang LJ, et al. Ann N Y Acad Sci. 2010 Apr;1193:111-6. doi: 10.1111/j.1749-6632.2009.05343.x. Ann N Y Acad Sci. 2010. PMID: 20398015 Review.
Four new phenolic glycosides from Dobinea delavayi.
Wu XR, Lang LJ, Shen Y, Dong X, Xiao CJ, Jiang B. Wu XR, et al. Among authors: lang lj. Nat Prod Res. 2021 Oct 26:1-8. doi: 10.1080/14786419.2021.1994966. Online ahead of print. Nat Prod Res. 2021. PMID: 34702089
The Complexity of DEK Signaling in Cancer Progression.
Teng Y, Lang L, Jauregui CE. Teng Y, et al. Among authors: lang l. Curr Cancer Drug Targets. 2018;18(3):256-265. doi: 10.2174/1568009617666170522094730. Curr Cancer Drug Targets. 2018. PMID: 28530531 Review.
714 results